In conclusion, tumour cells expressed both VEGF-C and VEGFR-3 in NSCLC (autocrine loop), and other normal cells (macrophages, type II pneumocytes and lymph vessels) also expressed VEGF-C and/or VEGFR-3. This evidence concerns the gene FLT4 and neoplasm.